Evidence map›Paper›PMID 36891928›Full record

ArticleMaternal & child nutrition2023

Marketing of commercial milk formula during COVID-19 in Indonesia.

Irma Hidayana, Lianita Prawindarti, Nia Umar, Kusmayra Ambarwati, Fitria Rosatriani

Open access · goldAbstract read
In one paragraph

Article in Maternal & child nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Irma HidayanaPelanggaranKode, Jakarta, Indonesia.ORCID 0000-0001-7238-9893
Lianita PrawindartiPelanggaranKode, Jakarta, Indonesia.
Nia UmarPelanggaranKode, Jakarta, Indonesia.
Kusmayra AmbarwatiPelanggaranKode, Jakarta, Indonesia.
Fitria RosatrianiPelanggaranKode, Jakarta, Indonesia.
Indonesian Pediatric Society · IDSt. Lawrence University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Baby food marketing poses a substantial barrier to breastfeeding, which adversely affects mothers' and children's health. Over the last decade, the baby food industry has utilised various marketing tactics in Indonesia, including direct marketing to mothers and promoting products in public spaces and within the healthcare system. This study examined the marketing of commercial milk formula (CMF) and other breast-milk substitute products during the COVID-19 pandemic in Indonesia. Using a local, community-based reporting platform, information on publicly reported violations of the International Code of Marketing of Breast-milk Substitutes and subsequent World Health Assembly resolutions (the Code) was collected. It was found that a total of 889 reported cases of unethical marketing of such products were recorded primarily through social media from May 20 through December 31, 2021. Our results suggest that the COVID-19 pandemic has provided more opportunities for the baby food industry in Indonesia to attempt to circumvent the Code aggressively through online marketing strategies. These aggressive marketing activities include online advertisements, maternal child health and nutrition webinars, Instagram sessions with experts, and heavy engagement of health professionals and social media influencers. Moreover, product donations and assistance with COVID-19 vaccination services were commonly used to create a positive image of the baby food industry in violation of the Code. Therefore, there is an urgent need to regulate the online marketing of milk formula and all food and beverage products for children under the age of 3.

Indexed as

COVID-19Milk SubstitutesAnimalsBreast FeedingChild, PreschoolCOVID-19 VaccinesFemaleHumansIndonesiaInfantInfant, NewbornMarketingMilkPandemicsCOVID-19 Vaccinesaggressive marketingcode of marketingCOVID-19Indonesiamilk formulaonline marketingpandemic

Identifiers

PMID36891928
PMCPMC10262905
OpenAlexW4323653049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.